Psilocybin-Assisted Alcohol Use Disorder Outpatient Program A structured addiction treatment service combining two supervised psilocybin sessions with motivational enhancement and cognitive-behavioral therapy, targeting AUD patients where the clinical trial cut heavy drinking days from 23.6% to 9.7% over 32 weeks.
Why it helps: NIAAA funds AUD treatment research and would benefit from a clinical program that operationalizes the [3] trial findings, generates real-world evidence, and informs regulatory strategy for psilocybin in AUD.